Takeda (Germany)

Recent papers from Takeda (Germany)

1. Clinical and Cost-Effectiveness of Shared Decision Making: Evidence from a Prospective Multicenter Study Evaluating a Hospital-Based Intervention in GermanyMedical Decision Making · 2026
2. Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world settingTherapeutic Advances in Hematology · 2026
3. Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive ProteinJournal of the American College of Cardiology · 2007
4. Healthcare resource utilization and cost in pediatric celiac disease: A case‐control study using German insurance dataJournal of Pediatric Gastroenterology and Nutrition · 2025
5. Seizure classification using a multimodal seizure monitoring system (Nelli) in Dravet and Lennox–Gastaut syndromes: A non‐randomized, single‐center feasibility studyEpilepsia · 2025
6. Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in EuropeCytotherapy · 2025
7. Incidence and Long‐Term Outcomes of Pouchitis in Ulcerative Colitis PatientsUnited European Gastroenterology Journal · 2025
8. Primary endpoint acceptance and its association with benefit ratings and market access in German health technology assessments: a retrospective cohort studyThe Lancet Regional Health - Europe · 2025
9. Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment—real world comparative effectiveness from German claims dataBMC Gastroenterology · 2025
10. Ixazomib-lenalidomid-dexamethasone (IRd) in relapsed refractory multiple myeloma (RRMM)—multicenter real-world analysis from Germany and comparative review of the literatureAnnals of Hematology · 2025
11. Burden of coeliac disease in Germany: real-world insights from a large retrospective health insurance claims database analysisTherapeutic Advances in Gastroenterology · 2025
12. Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of fruquintinib + best supportive care (BSC) compared with placebo + BSC in metastatic colorectal cancer (mCRC): Results from the FRESCO-2 trial.Journal of Clinical Oncology · 2024
13. Epidemiology and treatment of children with hereditary angioedema in Germany: A retrospective database studyClinical and Translational Allergy · 2023
14. The epidemiology and burden of gastroparesis: Real‐world data from a large healthcare provider in IsraelNeurogastroenterology & Motility · 2023
15. Convenient Access to Expert-Reviewed Health Information via an Alexa Voice Assistant Skill for Patients With Multiple Myeloma: Development StudyJMIR Cancer · 2022
16. Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims dataInfection · 2022
17. Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT StudyAdvances in Therapy · 2022
18. Epidemiology, Diagnostics, and Treatment of Narcolepsy in Germany: The DORMIO StudyJournal of Sleep Medicine · 2021
19. Novel Approaches Identifying Relevant Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases—LISTEN 1Crohn s & Colitis 360 · 2021
20. Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell ImmunotherapyFrontiers in Immunology · 2021